RECORD // Company

Exelixis, Inc.

Formerly: EXELIXIS INC

Built 2026-11-21T11:35:38Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
  • Exelixis, Inc. · legal entity in this company's GLEIF ownership tree (LEI 254900PJQB59O2O95R37)
SEC EDGAR (1)
Matched by name only, not merged (25)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Exelixis · Ca breach · exact name match to 'EXELIXIS, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • Exelixis Us, LLC · Ca business · exact name match to 'EXELIXIS, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • Exelixis, Inc. · Ca business · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS U.S., LLC · Ct business · exact name match to 'EXELIXIS, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS, INC. · Ct business · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Exelixis U.S., LLC · Ct business · exact name match to 'EXELIXIS, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • Exelixis · Ctgov · exact name match to 'EXELIXIS, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • Exelixis Inc. · East licences · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Exelixis U.S., LLC · East licences · exact name match to 'EXELIXIS, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS · Epa echo · exact name match to 'EXELIXIS, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS INC · Epa echo · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS INC · Epa echo · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS INC · Epa echo · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS, INC · Epa echo · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS, INC · Epa echo · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS, INC. · Epa rcra · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS INC. (lobbying via EXELIXIS INC.) · LDA lobbying · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS, INC. (lobbying via ARNOLD & PORTER KAYE SCHOLER LLP) · LDA lobbying · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS, INC. (lobbying via EAST END GROUP, LLC) · LDA lobbying · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS, INC. (lobbying via LMH STRATEGIC SOLUTIONS) · LDA lobbying · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS, INC. (lobbying via TODD STRATEGY GROUP) · LDA lobbying · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS, INC. (lobbying via W STRATEGIES, LLC) · LDA lobbying · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS U.S., LLC · Ny corps · exact name match to 'EXELIXIS, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS, INC. · Ny corps · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EXELIXIS, INC. · USAspending · same registered legal name as 'EXELIXIS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare

6 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-10-02, filed 2026-10-29 · accession 0000939767-26-000116

ItemValuePeriodFormFiledAccessionReport
Revenue$658,696,0003 months ended 2026-10-0210-Q2026-10-290000939767-26-0001162026-11-21 11:35 UTCReport an error
Net income (loss)$218,095,0003 months ended 2026-10-0210-Q2026-10-290000939767-26-0001162026-11-21 11:35 UTCReport an error
Cash and cash equivalents$304,774,000at 2026-10-0210-Q2026-10-290000939767-26-0001162026-11-21 11:35 UTCReport an error
Contract liabilities (total)$5,122,000at 2026-10-0210-Q2026-10-290000939767-26-0001162026-11-21 11:35 UTCReport an error
Contract liabilities, current$1,081,000at 2026-10-0210-Q2026-10-290000939767-26-0001162026-11-21 11:35 UTCReport an error
Contract liabilities, noncurrent$4,041,000at 2026-10-0210-Q2026-10-290000939767-26-0001162026-11-21 11:35 UTCReport an error

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0000939767
Ticker
EXEL
EIN
043257395
CUSIP
30161Q104
Record ID
sx:sec:0000939767

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

37 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-09SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-09SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
State of incorporationDE2026-11-09SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
Fiscal year end (MMDD)01012026-11-09SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
Business address1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 945022026-11-09SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
ExchangesNasdaq2026-11-09SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
Revenue (fiscal year ended 2026-01-02)$2,320,126,0002026-01-0210-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-21 11:35 UTCReport an error
Net income (loss) (fiscal year ended 2026-01-02)$782,570,0002026-01-0210-K, XBRL NetIncomeLoss2026-11-21 11:35 UTCReport an error
Total assets (at 2026-01-02)$2,844,423,0002026-01-0210-K, XBRL Assets2026-11-21 11:35 UTCReport an error
Stockholders' equity (at 2026-01-02)$2,161,319,0002026-01-0210-K, XBRL StockholdersEquity2026-11-21 11:35 UTCReport an error
Cash and cash equivalents (at 2026-01-02)$482,488,0002026-01-0210-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-21 11:35 UTCReport an error
Operating cash flow (fiscal year ended 2026-01-02)$884,267,0002026-01-0210-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 11:35 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2026-01-02)$8,429,0002026-01-0210-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 11:35 UTCReport an error
Operating lease liabilities (at 2026-01-02)$200,920,0002026-01-0210-K, XBRL OperatingLeaseLiability2026-11-21 11:35 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-10-29)On October 29, 2026, Exelixis, Inc. (Exelixis) issued a press release announcing its financial results for the quarter ended October 2, 2026, and providing a corporate update. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this report, including the exhibit hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this report and in the accompanying exhibit shall not be incorporated by reference into…2026-10-29SEC EDGAR 8-K 0000939767-26-000114 (text as filed, excerpt)2026-11-21 11:35 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-09-11)Today, Exelixis, Inc. (Exelixis) announced that on September 10, 2026, the U.S. Food and Drug Administration (FDA) notified Exelixis that it had extended the review period for Exelixis’ new drug application (NDA) for zanzalintinib, in combination with atezolizumab, for the treatment of patients with metastatic colorectal cancer by three months. In response to an FDA information request, Exelixis had submitted updated safety and efficacy data, which the FDA has deemed a major amendment. The updated Prescription Drug User Fee Act action date is March 3, 2027.2026-09-11SEC EDGAR 8-K 0000939767-26-000108 (text as filed, excerpt)2026-11-21 11:35 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-08-31)On August 31, 2026, Exelixis, inc. (Exelixis) announced that the U.S. Court of Appeals for the Federal Circuit (Court of Appeals) issued a decision in Exelixis, Inc. v. MSN Laboratories Private Limited et al., Appeal No. 25-1236, affirming the judgment of the U.S. District Court for the District of Delaware that U.S. Patent Nos. 11,091,439, 11,091,440 and 11,098,015 are not invalid. The Court of Appeals also dismissed as moot MSN’s appeal relating to the validity of U.S. Patent No. 11,298,349, which expires on February 10, 2032, and vacated the portion of the district court’s decision addressing that issue. Based on the Court of Appeals’ opinion, the effective date of any final approval by…2026-08-31SEC EDGAR 8-K 0000939767-26-000104 (text as filed, excerpt)2026-11-21 11:35 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-05)On August 5, 2026, Exelixis, Inc. (Exelixis) issued a press release announcing its financial results for the quarter ended July 3, 2026, and providing a corporate update. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this report, including the exhibit hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this report and in the accompanying exhibit shall not be incorporated by reference into any…2026-08-05SEC EDGAR 8-K 0000939767-26-000096 (text as filed, excerpt)2026-11-21 11:35 UTCReport an error
Employer name (as filed)Exelixis, Inc.2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Certified LCAs92026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Certified LCAs later withdrawn02026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Total worker positions on certified LCAs92026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Top job titles (title, LCA count)GPS (PV / Drug Safety) Systems Manager (2); Senior Corporate Counsel, Corporate & Securities (2); Senior Statistical Programming Manager (1); Statistical Programming Manager (1); Assoc. Principal IT Product Lead-Quality &Regulatory Systems (1)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Wage offered, annualized (n, min, median, max)median $186,515 (range $165,000-$305,101, 9 filings)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Worksite statesCA2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Plan (pension, plan no. 001)EXELIXIS, INC. 401(K) PLAN: 1,836 participants, assets $402,452,7332025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:35 UTCReport an error
Plan (welfare, plan no. 502)EXELIXIS, INC. HEALTH AND WELFARE PLAN: 1,221 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:35 UTCReport an error
Largest institutional holder #1 (13F as filed): BlackRock, Inc.$1,581,991,2742026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #2 (13F as filed): FARALLON CAPITAL MANAGEMENT, L.L.C.$732,794,4242026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #3 (13F as filed): RENAISSANCE TECHNOLOGIES LLC$730,617,0992026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #4 (13F as filed): VANGUARD PORTFOLIO MANAGEMENT LLC$655,266,2682026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #5 (13F as filed): AQR CAPITAL MANAGEMENT LLC$598,600,1202026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #6 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$595,843,7472026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #7 (13F as filed): STATE STREET CORP$542,471,5632026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #8 (13F as filed): FULLER & THALER ASSET MANAGEMENT, INC.$485,848,0302026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #9 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$416,318,9152026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #10 (13F as filed): D. E. Shaw & Co., Inc.$302,070,5542026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.